Table 3

Summary of results from volumetric analysis*

 Structures
Hipp,LHipp,RCaud,LCaud,RPuta,LPuta,RPall,LPall,R
All participants
 Estimate−80.48−52.16−6.9220.500−4.980−6.4234.521−19.44
 SE27.3024.6121.9223.6231.1027.0916.4714.12
 Significance0.0380.0350.7520.9830.8730.8130.7840.170
Participants with NFG
 Estimate−50.22−26.41−35.38−7.746−66.37−23.73−5.678−11.71
 SE53.2646.8843.3846.9461.7053.0632.8027.48
 Significance0.3470.5740.4160.8690.2830.6550.8630.670
Participants with diabetes
 Estimate−64.67−47.9840.1620.5988.0078.5918.47−3.663
 SE40.6350.7324.6428.6136.5141.9823.3819.76
 Significance0.1300.3570.1220.4810.0280.0790.4400.855
Participants with NFG vs diabetes
 Estimate−64.46−198.4−86.65−127.6−298.0−312.6−88.00−112.3
 SE97.5386.7277.8883.55110.796.7558.8649.20
 Significance0.5090.0230.2670.1280.0080.0010.1360.023
  • *Summary of results from volumetric analysis of left (L) and right (R) hippocampus (Hipp), caudate (Caud), putamen (Puta) and globus pallidus (Pall), correlating plasma glucose levels with volumetric differences (mm3/mmol/L) among all participants, participants with normal fasting plasma glucose levels (NFG) and participants with diabetes, as well as comparing participants with NFG with participants with diabetes (mm3). Statistically significant values (p<0.05) are marked bold.